Export

Itraconazole
Essential medicine status
General description
Itraconazole is an azole antifungal indicated for the prevention and/or treatment of various local and systemic fungal infections.
INN
Itraconazole
Medicine type
Chemical agent
EML status history
Application rejected in 2015 (TRS 994) for Chronic pulmonary aspergillosis
Added in 2017 (TRS 1006) for Sporotrichosis
Added in 2017 (TRS 1006) for Chromoblastomycosis
Added in 2017 (TRS 1006) for Histoplasmosis
Added in 2017 (TRS 1006) for Penicilliosis
Therapeutic equivalent for
Wikipedia
Recommendations
Section
Antifungal medicines
  • Oral > Liquid: 10 mg per mL
  • Oral > Solid: 100 mg